CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

Gammaplex 5% & 10%

Gammaplex 5%Gammaplex 10%Neutral
AI Analysis

Summary

Gammaplex 5% and 10% are indicated for the treatment of primary humoral immunodeficiency in adults and pediatric patients aged two years and older, and for chronic immune thrombocytopenic purpura.

Importance:1/10
Sentiment:
0.00
GammapleximmunodeficiencyITPimmunoglobulin

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on July 17, 2026 10:52 AM

Read Original